Trial intelligence / Profile preview

Erector Spinae Blocks for Thoracic Surgery

NCT05521789Phase 4Recruiting

Sponsor
George Washington University
Start
Jul 2022
Primary completion
Dec 2026
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of bupivacaine in Persistent postsurgical pain (PPSP), sponsored by George Washington University. Started Jul 2022; status: recruiting.

02

Drugs

bupivacaine
03

Conditions

Persistent postsurgical pain (PPSP)

Beyond the preview

Go deeper on NCT05521789.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05521789.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call